MICHAEL CURTIS: Open Payments
NPI 1336280759 · LINDON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 63 payments from 22 companies in 2025. Trend: 2023 $1,163 · 2024 $1,196 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $242 |
| AstraZeneca Pharmaceuticals LP | 7 | $162 |
| Astellas Pharma US Inc | 5 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $83 |
| Viatris Specialty LLC | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 5 | $61 |
| Lilly USA, LLC | 3 | $48 |
| PFIZER INC. | 3 | $46 |
| Abbott Laboratories | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $29 |
Products named: VRAYLAR, AIRSUPRA, Veozah, Kerendia, YUPELRI, VOQUEZNA, FREESTYLE LIBRE 3, UBRELVY.
Industry payments across UT — which companies pay providers there.
